Li et al. demonstrated that ST2-deficient mice have attenuated bleomycin-induced lung fibrosis, and this phenomenon could be recreated by IL-33 neutralising antibody treatment [141]. This evidence concerns the gene IL33 and pulmonary fibrosis.